Abeer Shibli

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT

Hannah Kinoshita, Kenneth R. Cooke, Melanie Grant et al. · Blood Advances · 2022 · 39 citations · Full text

Medicine, Hematology, Immunology +17

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

Michael D. Keller, Patrick J. Hanley, Yueh‐Yun Chi et al. · Nature Communications · 2024 · 25 citations · Full text

Life Sciences, Hematology, Immunology +17

Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma

Hema Dave, Madeline Terpilowski, Mimi Mai et al. · Blood Advances · 2021 · 18 citations · Full text

Medicine, Immunology, Oncology +17

The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy

Cynthia L. Gay, Patrick J. Hanley, Shane D. Falcinelli et al. · The Journal of Infectious Diseases · 2024 · 13 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease

Hannah Kinoshita, Mamatha Mandava, Mariah Jensen-Wachspress et al. · Blood Advances · 2022 · 10 citations · Full text

Medicine, Hematology, Immunology +13